Illumina
Trade Illumina 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About ILMN
Illumina, Inc. engages in the development, manufacturing, and marketing of life science tools and integrated systems for large-scale analysis of genetic variation and function. It operates through the Core Illumina segment, which serves customers in the research, clinical and applied markets fields, and enables the adoption of a variety of genomic solutions.
ILMN Key Statistics
Stock Snapshot
The current Illumina(ILMN) stock price is $134.57, with a market capitalization of 20.57B. The stock trades at a price-to-earnings (P/E) ratio of 23.38.
On 2026-02-28, Illumina(ILMN) stock moved within a range of $127.01 to $134.76. With shares now at $134.57, the stock is trading +6.0% above its intraday low and -0.1% below the session's peak.
Trading activity shows a volume of 4.01M, compared to an average daily volume of 2.53M.
The stock's 52-week range extends from a low of $68.70 to a high of $155.53.
The stock's 52-week range extends from a low of $68.70 to a high of $155.53.
ILMN News
Illumina, the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Kyle Mikson CFA from Canaccord Genuity maintained a Hold rati...
TD Cowen analyst Dan Brennan says Roche (RHHBY) yesterday announced the consumables price for the Xpandomer-based nanopore sequencer, Axelios, at $150 per genom...
Illumina (ILMN) is back in focus for investors after recent trading moves, with the stock showing mixed performance across different time frames and a meaningfu...
Analyst ratings
43%
of 23 ratingsMore ILMN News
Illumina (NasdaqGS:ILMN) introduced TruPath Genome, a whole genome sequencing solution designed to improve accuracy, workflow efficiency, and cost effectiveness...
New insider activity at Illumina ( (ILMN) ) has taken place on February 24, 2026. Illumina’s Chief Legal Officer, Scott M. Davies, has trimmed his stake in the...
In the months to 11 February 2026, Illumina completed a share repurchase program, buying back 9,958,000 shares, or 6.31% of its stock, for US$1.02 billion, whil...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.